Biogen shares soar 32% on MS drug patent win over Mylan

·

·

Biogen shares soar 32% on MS drug patent win over Mylan

(Reuters) – Biogen Inc’s shares surged as much as 32% on Wednesday after the drugmaker won a favorable U.S. patent ruling for its main multiple sclerosis drug Tecfidera in a battle with Mylan NV. FILE PHOTO: A sign marks a Biogen facility in Cambridge, …
See Original Article

Cognizant Technology posts lower Q4 profit

Cognizant Technology Solutions Corp. CTSH, +2.43% said profit fell in the fiscal fourth quarter as costs and expenses ticked higher. The New Jersey professional-services firm reported a quarterly profit of $395 million, or 72 cents a share, down from $648 …
See Original Article

Promotions Eat into Grubhub's Profit

Grubhub Inc. reported a loss in its most recent quarter, evidence of the pressure on food-delivery companies vying for customers with discounts and expansion efforts. The Chicago-based company on Wednesday said sales rose to $341 million for the quarter …
See Original Article

Tesla's stock falls 20% in a dramatic stumble from its all-time high

New York (CNN Business) Tesla’s Wall Street rally took a sharp U-turn Wednesday. The company’s shares fell as much as 20.6% Wednesday, paring back a meteoric rise that had driven the stock up 36% between Friday and Tuesday and pushed it to $968 at …
See Original Article

7-Eleven pilots cashierless store format

Convenience store giant 7-Eleven has begun testing a cashierless, checkout-free store for at its corporate headquarters in Irving, Texas. 7-Eleven said Wednesday that the 700-square-foot store is only for employees, who first must download an app and sign …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.